Linking traumatic brain injury to neurodegenerative disease
Scientists have revealed a potential mechanism for how traumatic brain injury leads to neurodegenerative diseases, according to a study in fruit flies, and rat
Stay updated with breaking news from Brain Tissue. Get real-time updates on events, politics, business, and more. Visit us for reliable news and exclusive interviews.
Scientists have revealed a potential mechanism for how traumatic brain injury leads to neurodegenerative diseases, according to a study in fruit flies, and rat
NeuroOne Medical Technologies Corporation (NASDAQ: NMTC; NeuroOne or the Company), a medical technology company focused on improving surgical care options and outcomes for patients suffering from neurological disorders, announces today the formation of a six member advisory board of leading neurosurgeons to assist in the completion of development of a radio frequency ablation electrode intended to record and ablate brain tissue linked to causing seizure activity.
Any amount of alcohol can cause damage to the brain, and more so than previously realized, according to a study in what researchers call one of the largest of its kind to date.
All mainstream network operators in New Zealand are steadily deploying 5G across the country. While we explore the scale of innovation and growth that 5G offers in almost all sectors of life, researchers around the world are already working on 6G – the sixth generation of mobile phone technology. This obviously raises at least six basic questions: Do we really need 6G? That largely depends on the trend of how much data we, the users, exchange using our mobile devices. A network can only handle a limited amount of data sent or received by the users, which can be roughly packaged as ‘user d...
Share: First Data Presented Showcasing Autobahn's Novel FAAH-Mediated Prodrug Approach for Selective Delivery of Thyromimetics to the Brain Treatment with ABX-002 Leads to Reductions in VLCFA in Brain Tissue and Plasma in AMN Mouse Model Autobahn Therapeutics, a biotechnology company focused on restoring hope for people affected by CNS disorders, today announced the presentation of preclinical data of ABX-002, a CNS-penetrating prodrug that provides a balanced delivery of LL-340001, a potent and selective thyroid hormone receptor beta (TRβ) agonist, for the potential treatment of adrenomye...